Skip to main content Skip to main navigation menu Skip to site footer

Hubungan disfungsi ereksi pada pasien dislipidemia dengan lama pengobatan statin di Puskesmas Denpasar Barat I

Abstract

Introduction: There has been change in people's lifestyles that affect disease patterns, and dyslipidemia is one of those disease. Statins are the main pharmacological therapy for dyslipidemia. Many studies have researched the relationship between statin therapy in dyslipidemia and erectile dysfunction. However, existing research has not specifically explained this relationship.

Objective: This study aims to determine the relationship between erectile dysfunction in dyslipidemic patients and duration of statin treatment at Community Health Center I West Denpasar.

Methods: This research is analytic observational with cross sectional design. The study was conducted on dyslipidemic patients who took statins and met inclusion and exclusion criteria at Community Health Center I West Denpasar in May-June 2021. The sample size was 35. Duration of statin consumption was obtained through medical records and reconfirmed through questionnaire. Erectile dysfunction was measured by IIEF-5 questionnaire. Data analysis using SPSS version 21 with chi square test and Cramer's V correlation test.

Results: The prevalence of erectile dysfunction in dyslipidemic patients with statin treatment at Community Health Center I West Denpasar was 85.7% with majority of the patients experiencing mild erectile dysfunction (37.1%) and taking statins for less than 12 months (51.4%). Characteristics of the patients were mostly aged 45-60 years (74.2%), obesity I (42.8%), smoking (60%), and drinking alcohol (57%). Statistical tests showed significant relationship between erectile dysfunction in dyslipidemic patients and duration of statin treatment at Community Health Center I West Denpasar  (p=0.031) with moderate correlation (r=0.552). Statins with treatment duration >12 months had protective effect against erectile dysfunction (RR = 0.81).

Conclusion: There is a relationship between erectile dysfunction in dyslipidemic patients and duration of statin treatment with moderate correlation. Statins with duration of treatment >12 months have protective effect toward erectile dysfunction.

 

Pendahuluan: Terdapat perubahan gaya hidup masyarakat yang dapat memengaruhi pola penyakit pada manusia, dimana dislipidemia adalah salah satu penyakit tersebut. Statin merupakan salah satu terapi utama untuk dislipidemia. Terdapat banyak penelitian yang telah meneliti hubungan antara terapi statin pada dislipidemia dan disfungsi ereksi. Namun, penelitian yang ada belum secara spesifik menjelaskan hubungan ini.

 Tujuan: Penelitian ini bertujuan untuk mengetahui hubungan disfungsi ereksi pada pasien dislipidemia dengan lama pengobatan statin di Puskesmas Denpasar Barat I.

Metode: Penelitian ini adalah penelitian analitik observasional dengan desain cross-sectional. Penelitian dilakukan pada pasien dislipidemia yang mengonsumsu statin dan memenuhi kriteria inklusi dan eksklusi di Puskesmas Denpasar Barat I pada bulan Mei sampai Juni 2021. Sampel pada penelitian ini adalah 35 orang. Durasi konsumsi statin diperoleh melalui rekam medis dan dikonfirmasi ulang melalui kuisioner. Disfungsi ereksi diukur dengan kuisioner IIEF-5. Analisis data menggunakan SPSS versi 21 dengan uji chi-square dan uji korelasi Cramer’s V. 

Hasil: Prevalensi disfungsi ereksi pada pasien dislipidemia dengan pengobatan statin di Puskesmas Denpasar Barat I sebesar 85,7% dengan mayoritas pasien mengalami disfungsi ereksi ringan (37,1%) dan mengonsumsi statin kurang dari 12 bulan (51,4%). Karakteristik pasien sebagian besar berusia 45-60 tahun (74,2%), dengan obesitas I (42,8%), merokok (60%), dan minum alkohol (57%). Hasil uji statistic menunjukkan hubungan yang bermakna antara disfungsi ereksi pada pasien dislipidemia dengan lama pengobatan statin di Puskesmas Denpasar Barat I (p=0,031) dengan korelasi sedang (r=0,552). Statin dengan lama pengobatan lebih dari 12 bulan memiliki efek protektif terhadap disfungsi ereksi (RR = 0,81).

Kesimpulan: Terdapat hubungan antara disfungsi ereksi pada pasien dislipidemia dan lama pengobatan statin dengan korelasi sedang. Pengobatan statin dengan lama pengobatan lebih dari 12 bulan memiliki efek protektif terhadap disfungsi ereksi. 

References

  1. Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218–40. Available from: https://pubmed.ncbi.nlm.nih.gov/23584084
  2. Schooling CM, Au Yeung SL, Freeman G, Cowling BJ. The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials. BMC Med. 2013;11:57. Available from: https://pubmed.ncbi.nlm.nih.gov/23448151
  3. Corona G, Boddi V, Balercia G, Rastrelli G, De Vita G, Sforza A, et al. The Effect of Statin Therapy on Testosterone Levels in Subjects Consulting for Erectile Dysfunction. J Sex Med. 2010;7(4):1547–56. Available from: http://dx.doi.org/10.1111/j.1743-6109.2009.01698.x
  4. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation. Eur Urol. 2010;57(5):804–14. Available from: http://dx.doi.org/10.1016/j.eururo.2010.02.020
  5. Leong TMM, Oka Negara IM, Kurniawan Y. Pengaruh kebiasaan merokok terhadap kejadian disfungsi ereksi pada petugas keamanan di Universitas Udayana Sudirman. Intisari Sains Medis. 2019;10(3). Available from: http://dx.doi.org/10.15562/ism.v10i3.498
  6. La Vignera S, Condorelli RA, Vicari E, Calogero AE. Statins and Erectile Dysfunction: A Critical Summary of Current Evidence. J Androl. 2011;33(4):552–8. Available from: http://dx.doi.org/10.2164/jandrol.111.015230
  7. Cai X, Tian Y, Wu T, Cao C-X, Bu S-Y, Wang K-J. The role of statins in erectile dysfunction: a systematic review and meta-analysis. Asian J Androl. 2014;16(3):461–6. Available from: https://pubmed.ncbi.nlm.nih.gov/24556747
  8. Kostis JB, Dobrzynski JM. The Effect of Statins on Erectile Dysfunction: A Meta?Analysis of Randomized Trials. J Sex Med. 2014;11(7):1626–35. Available from: http://dx.doi.org/10.1111/jsm.12521
  9. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI. Riset Kesehatan Dasar (Riskesdas) tahun 2018. Jakarta; 2018.
  10. Sood R, Sharma D, Goel H, Khattar N, Kulshreshtha B, Singh KK. The correlation between erectile dysfunction and metabolic syndrome in an Indian population: A cross-sectional observational study. Arab J Urol. 2019;17(3):221–7. Available from: https://pubmed.ncbi.nlm.nih.gov/31489239
  11. Koampa PH, Pandelaki K, Wongkar MCP. Hubungan indeks massa tubuh dengan profil lipid pada pasien diabetes melitus tipe 2. e-CliniC. 2016;4(1). Available from: http://dx.doi.org/10.35790/ecl.4.1.2016.12106
  12. Sitepu JN. Hubungan Kualitas Tidur dengan Atensi pada Mahasiswa/ i Fakultas Kedokteran Universitas HKBP Nommensen Medan. Nommensen J Med. 2020;6(1):26–31. Available from: http://dx.doi.org/10.36655/njm.v6i1.261
  13. Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: A review. World J Diabetes. 2010;1(3):76–88. Available from: https://pubmed.ncbi.nlm.nih.gov/21537431
  14. Sharma P, Kumar P, Sharma R, K K, G G. Dyslipidemia Among Smokers. Asian J Pharm Clin Res. 2016;9(4 SE-Original Article(s)):137–8. Available from: https://innovareacademics.in/journals/index.php/ajpcr/article/view/11798
  15. Singh D. Effect of Cigarette Smoking on Serum Lipid Profile in Male Population of Udaipur. Biochem Anal Biochem. 2016;5(3). Available from: http://dx.doi.org/10.4172/2161-1009.1000283
  16. Shen Z, Munker S, Wang C, Xu L, Ye H, Chen H, et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. J Clin Lipidol. 2014;8(3):273–8. Available from: http://dx.doi.org/10.1016/j.jacl.2014.02.003
  17. Nisahan B, Kumanan T, Rajeshkannan N, Peranantharajah T, Aravinthan M. Erectile dysfunction and associated factors among men with diabetes mellitus from a tertiary diabetic center in Northern Sri Lanka. BMC Res Notes. 2019;12(1):210. Available from: https://pubmed.ncbi.nlm.nih.gov/30953562
  18. Roumeguère T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. Erectile Dysfunction Is Associated with a High Prevalence of Hyperlipidemia and Coronary Heart Disease Risk. Eur Urol. 2003;44(3):355–9. Available from: http://dx.doi.org/10.1016/s0302-2838(03)00306-3
  19. Sigglekow F, Horsburgh S, Parkin L. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users. PLoS One. 2020;15(11):e0242424–e0242424. Available from: https://pubmed.ncbi.nlm.nih.gov/33211724
  20. Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long-term statin therapy? Curr Atheroscler Rep. 2013;15(1):291. Available from: https://pubmed.ncbi.nlm.nih.gov/23225173
  21. Cui Y, Zong H, Yan H, Zhang Y. The Effect of Statins on Erectile Dysfunction: A Systematic Review and Meta?Analysis. J Sex Med. 2014;11(6):1367–75. Available from: http://dx.doi.org/10.1111/jsm.12497
  22. Nurkalem Z, Yildirimtürk Ö, Özcan KS, Kul ?, Çanga Y, Sat?lm?? S, et al. The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterolaemic patients. Kardiol Pol. 2014;72(3):275–9. Available from: http://dx.doi.org/10.5603/kp.a2013.0287
  23. Al-kuraishy H, Al-Gareeb A, Al-Maiahy T. Erectile dysfunction and statins: The assorted view of preponderance. Asian Pacific J Reprod. 2020;9(2):55. Available from: http://dx.doi.org/10.4103/2305-0500.281074

How to Cite

Pranamartha, A. A. G. R. I., Pramesemara, I. G. N., & Kurniawan, Y. K. (2021). Hubungan disfungsi ereksi pada pasien dislipidemia dengan lama pengobatan statin di Puskesmas Denpasar Barat I. Intisari Sains Medis, 12(3), 1011–1015. https://doi.org/10.15562/ism.v12i3.1100

HTML
58

Total
42

Share

Search Panel

Anak Agung Gde Ryantha Indra Pranamartha
Google Scholar
Pubmed
ISM Journal


I Gusti Ngurah Pramesemara
Google Scholar
Pubmed
ISM Journal


Yukhi Kurniawan Kurniawan
Google Scholar
Pubmed
ISM Journal